205
Views
5
CrossRef citations to date
0
Altmetric
Articles

Development of Care Pathways to Standardize and Optimally Integrate Multidisciplinary Care for Head and Neck Cancer

, MD, , MD, , MD, , MS, RD, CNSC, , MD, , MS, , MSN, RN, ACNS-BC, , MA, CCC-SLP, , PHARMD, BCOP, , MD, , MD, , MD, , MD, , MD, , MD, PHD, , MD, PHD, , DSW, LCSW, , OTR/L, CLT-LANA, , NP-C, , MPH & , MA, CCC-SLP, BCS-S show all

References

  • National Cancer Institute Surveillance, Epidemiology, and End Results Program. SEER Stat Fact Sheets. 2008. Available online at: http://seer.cancer.gov/statfacts/html/all.html. Last accessed April 30, 2018.
  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2): 87–108.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016; 66: 7–30.
  • Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist. 2010; 15: 994–1001.
  • Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010; 11: 781–789.
  • Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008; 100: 407–420.
  • Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998; 90: 1626–1636.
  • Applebaum KM, Furniss CS, Zeka A, et al. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst. 2007; 99: 1801–1810.
  • Argiris A, Li S, Ghebremichael M, et al. Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials. Ann Oncol. 2014; 25: 1410–1416.
  • Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; 100(4): 261–269.
  • Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010; 363: 24–35.
  • Seiwert TY, Cohen EEW. State-of-the-art management of locally advanced head and neck cancer. Br J Cancer. 2005; 92: 1341–1348.
  • Logan RM. Advances in understanding of toxicities of treatment for head and neck cancer. Oral Oncol. 2009; 45: 844–848.
  • Rieger JM, Zalmanowitz JG, Wolfaardt JF. Functional outcomes after organ preservation treatment in head and neck cancer: a critical review of the literature. Int J Oral Maxillofac Surg. 2006; 35: 581–587.
  • Connor NP, Cohen SB, Kammer RE, et al. Impact of conventional radiotherapy on health-related quality of life and critical functions of the head and neck. Int J Radiat Oncol Biol Phys. 2006; 65: 1051–1062.
  • Nguyen NP, Frank C, Moltz CC, et al. Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005; 61: 772–778.
  • Smith BG, Hutcheson KA, Little LG, et al. Lymphedema outcomes in patients with head and neck cancer. Otolaryngol Head Neck Surg. 2015; 152(2): 284–291.
  • Lo Nigro C, Denaro N, Merlotti A, Merlano M. Head and neck cancer: improving outcomes with a multidisciplinary approach. Cancer Manag Res. 2017; 9: 363–371.
  • David JM, Ho AS, Luu M, et al. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer. Cancer. 2017; 123: 3933–3942.
  • Kelly SL, Jackson JE, Hickey BE, Szallasi FG, Bond CA. Multidisciplinary clinic care improves adherence to best practice in head and neck cancer. Am J Otolaryngol. 2013; 34: 57–60.
  • National Comprehensive Cancer Network. Head and neck cancers 2018; Ver 2. Available online at: nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf. Last accessed April 30, 2018.
  • Blazeby JM, Wilson L, Metcalfe C, Nicklin J, English R, Donovan JL. Analysis of clinical decision-making in multi-disciplinary cancer teams. Ann Oncol. 2006; 17: 457–460.
  • Vanhaecht K, Sermeus W, Peers J, et al. The impact of care pathways for exacerbation of chronic obstructive pulmonary disease: rationale and design of a cluster randomized controlled trial. Trials. 2010; 11: 111–117.
  • Wentworth DA, Atkinson RP. Implementation of an acute stroke program decreases hospitalization costs and length of stay. Stroke. 1996; 27: 1040–1043.
  • Mosher C, Cronk P, Kidd A, McCormick P, Stockton S, Sulla C. Upgrading practice with critical pathways. Am J Nurs. 1992; 92: 41–44.
  • Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA. Speech and swallowing rehabilitation for head and neck cancer patients. Oncology. 1997; 11: 651–656, 659; discussion 659, 663–654.
  • Gaziano JE. Evaluation and management of oropharyngeal dysphagia in head and neck cancer. Cancer Control. 2002; 9: 400–409.
  • Gorenc M, Kozjek NR, Strojan P. Malnutrition and cachexia in patients with head and neck cancer treated with (chemo) radiotherapy. Rep Pract Oncol Radiother. 2015; 20(4): 249–258.
  • Langius JAE, Bakker S, Rietveld DHF, et al. Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy. Br J Cancer. 2013; 109: 1093–1099.
  • Unsal D, Mentes B, Akmansu M, Uner A, Oguz M, Pak Y. Evaluation of nutritional status in cancer patients receiving radiotherapy: a prospective study. Am J Clin Oncol. 2006; 29(2): 183–188.
  • van Bokhorst-de van der S, van Leeuwen PA, Kuik DJ, et al. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer. 1999; 86: 519–527.
  • National Comprehensive Cancer Network. Survivorship 2017; Ver 3. Available online at: nccn.org/professionals/physician_gls/pdf/survivorship.pdf. Last accessed April 30, 2018.
  • Spotanski K, Ridner SH. Head and neck lymphedema. National Lymphedema Network Lymph Link. 2016; 29(2): 3–5.
  • Su T-L, Chen A-N, Leong C-P, et al. The effect of home-based program and outpatient physical therapy in patients with head and neck cancer: a randomized, controlled trial. Oral Oncol. 2017; 74: 130–134.
  • Guru K, Manoor U, Supe S. A comprehensive review of head and neck cancer rehabilitation: physical therapy perspectives. Indian J Palliat Care. 2012; 18(2): 87–97.
  • Press NA. From cancer patient to cancer survivior lost in transition. 2018. Available online at: georgiacore.org/articleImages/articlePDF_396.pdf. Last accessed April 30, 2018.
  • Cohen EE, LaMonte SJ, Erb NL, et al. American Cancer Society head and neck cancer survivorship care guideline. CA Cancer J Clin. 2016; 66(3): 203–239.
  • Freund KM, Battaglia TA, Calhoun E, et al. National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures. Cancer. 2008; 113: 3391–3399.
  • Oncology Nursing Society. Oncology Nurse Navigator Core Competencies. 2013. Available online at: bit.ly/1PifoCx. Last accessed January 20, 2016.
  • Bensink ME, Ramsey SD, Battaglia T, et al. Costs and outcomes evaluation of patient navigation after abnormal cancer screening: evidence from the Patient Navigation Research Program. Cancer. 2014; 120: 570–578.
  • Esparza A. Patient navigation and the American Cancer Society. Semin Oncol Nurs. 2013; 29(2): 91–96.
  • Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys. 2009; 73: 779–788.
  • American Academy of Audiology. Position statement and clinical practice guidelines: ototoxicity monitoring. 2009. Available online at: http://audiology-web.s3.amazonaws.com/migrated/OtoMonGuidelines.pdf_539974c40999c1.58842217.pdf. Last accessed April 30, 2018.
  • Foxhall LE, Rodriguez MA. Advances in Cancer Survivorship Management. 1st ed. New York, NY: Springer-Verlag; 2015.
  • American Speech-Language-Hearing Association. Audiologic management of individuals receiving cochleotoxic drug therapy [Guidelines]. 1994. Available online at: www.asha.org/policy. Last accessed September 10, 2018.
  • American Speech-Language-Hearing Association. Ototoxicity monitoring protocol. 2013. Available online at: http://asha.org/uploadedFiles/ASHA/Article/Ototoxicity-Monitoring-Protocol-Flowchart.pdf. Last accessed April 30, 2018.
  • Campbell KC, Durrant J. Audiologic monitoring for ototoxicity. Otolaryngol Clin North Am. 1993; 26: 903–914.
  • Murphy CT, Galloway TJ, Handorf EA, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016; 34(2): 169–178.
  • Rieke K, Schmid KK, Lydiatt W, Houfek J, Boilesen E, Watanabe-Galloway S. Depression and survival in head and neck cancer patients. Oral Oncol. 2017; 65: 76–82.
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606–613.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.